Company logo

DLB - Dolby Laboratories, Inc.

NYSE -> Technology -> Information Technology Services
San Francisco, United States
Type: Equity

DLB price evolution
DLB
(in millions $) 30 Oct 2024 30 Jul 2024 31 Mar 2024 31 Dec 2023
Current assets
Cash $778.62 $824.36 $708.66
Short term investments $127.32 $115.86 $140.82
Net receivables $512.94 $476.65 $525.3 $510.79
Inventory $33.73 $34.72 $35.8 $37.57
Total current assets $1194.42 $1468.65 $1551.74 $1451.36
Long term investments $117.9 $127.97 $92.88
Property, plant & equipment $518.15 $517.54 $524.55 $517.32
Goodwill & intangible assets $553.1 $560.8 $570.33
Total noncurrent assets $1504.98 $1492.99 $1484.17
Total investments $245.22 $243.84 $233.7
Total assets $3109.93 $2973.64 $3044.73 $2935.53
Current liabilities
Accounts payable $17.38 $297.02 $382.61 $341.58
Deferred revenue $32.65 $37.7 $33.4
Short long term debt $12.57 $14.21 $12.92
Total current liabilities $417.84 $354.54 $442.9 $394.1
Long term debt $35.62 $37.71 $34.32
Total noncurrent liabilities $171.67 $164.14 $179.12
Total debt $48.19 $51.92 $47.24
Total liabilities $632.77 $526.2 $607.04 $573.22
Shareholders' equity
Retained earnings $2496.26 $2462.93 $2449.88 $2367.18
Other shareholder equity -$19.1 -$30.17 -$29.07 -$21.43
Total shareholder equity $2432.85 $2420.9 $2345.85
(in millions $) 27 Oct 2024 31 Dec 2023 31 Dec 2022 31 Dec 2021
Current assets
Cash $817.97 $628.37 $1233.03
Short term investments $139.15 $189.21 $38.84
Net receivables $512.94 $444.38 $419.69 $414.93
Inventory $33.73 $35.62 $23.55 $10.96
Total current assets $1194.42 $1487.8 $1310.89 $1760.5
Long term investments $97.81 $102.51 $62.82
Property, plant & equipment $518.15 $521.78 $560.01 $601.51
Goodwill & intangible assets $575.84 $477.41 $463.58
Total noncurrent assets $1491.96 $1378.65 $1345.19
Total investments $236.96 $291.73 $101.66
Total assets $3109.93 $2979.77 $2689.55 $3105.69
Current liabilities
Accounts payable $17.38 $372.32 $244.41 $280.51
Deferred revenue $31.5 $18.59 $18.47
Short long term debt $13.63 $13.26 $15.4
Total current liabilities $417.84 $422.23 $277.52 $315.72
Long term debt $37.02 $37.69 $56.72
Total noncurrent liabilities $185.36 $161.01 $185.74
Total debt $50.65 $50.94 $72.12
Total liabilities $632.77 $607.58 $438.53 $501.45
Shareholders' equity
Retained earnings $2496.26 $2391.99 $2297.73 $2607.91
Other shareholder equity -$19.1 -$36.98 -$51.64 -$10.03
Total shareholder equity $2355.1 $2246.18 $2597.98
(in millions $) 30 Oct 2024 30 Jul 2024 31 Mar 2024 31 Dec 2023
Revenue
Total revenue $364.52 $315.57
Cost of revenue $38.78 $32.06
Gross Profit $325.75 $283.51
Operating activities
Research & development $62.49 $67.03
Selling, general & administrative $156.78 $144.17
Total operating expenses $216.78 $217.29
Operating income $108.97 $66.22
Income from continuing operations
EBIT $112.77 $71.05
Income tax expense $23.53 $13.25
Interest expense -$8.6 -$9.19
Net income
Net income $97.83 $66.98
Income (for common shares) $97.83 $66.98
(in millions $) 27 Oct 2024 31 Dec 2023 31 Dec 2022 31 Dec 2021
Revenue
Total revenue $1273.72 $1299.74 $1253.79 $1281.26
Cost of revenue $152.57 $141.36 $130.03
Gross Profit $1133.22 $1147.18 $1112.43 $1151.23
Operating activities
Research & development $271.52 $261.17 $253.64
Selling, general & administrative $612.84 $634.03 $556.83
Total operating expenses $868.51 $931.42 $905.83 $806.84
Operating income $215.75 $206.6 $344.39
Income from continuing operations
EBIT $220.98 $215.86 $347.39
Income tax expense $48.16 $48.41 $31.38 $36.69
Interest expense $50.08 -$28.09 $0.39 $0.48
Net income
Net income $261.82 $200.66 $184.09 $310.23
Income (for common shares) $200.66 $184.09 $310.23
(in millions $) 27 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Net income $38.44 $97.83 $66.98
Operating activities
Depreciation $21.21 $20.78 $20.96
Business acquisitions & disposals
Stock-based compensation $29.34 $28.91 $31.89
Total cash flows from operations $21.26 $181.41 $8.41
Investing activities
Capital expenditures -$7.61 -$8.92 -$6.1
Investments -$0.13 -$8.96 $6.73
Total cash flows from investing -$286.29 -$7.74 -$17.87 $0.63
Financing activities
Dividends paid -$114.58 -$28.7 -$28.72 -$28.55
Sale and purchase of stock -$26.23 -$15.45 -$96.26
Net borrowings
Total cash flows from financing -$287.81 -$58.4 -$44.16 -$125.14
Effect of exchange rate $6.64 -$0.86 -$3.68 $6.79
Change in cash and equivalents -$240.21 -$45.73 $115.7 -$109.31
(in millions $) 27 Oct 2024 31 Dec 2023 31 Dec 2022 31 Dec 2021
Net income $200.66 $184.09 $310.23
Operating activities
Depreciation $95.51 $103.61 $112.76
Business acquisitions & disposals $25.7 -$38.17 -$4.5
Stock-based compensation $118.49 $114.92 $99.7
Total cash flows from operations $367.08 $318.58 $447.75
Investing activities
Capital expenditures -$30.34 -$59.46 -$38.09
Investments $58.84 -$198.31 -$2.32
Total cash flows from investing -$286.29 $54.21 -$295.94 -$44.91
Financing activities
Dividends paid -$114.58 -$103.41 -$100.07 -$89.17
Sale and purchase of stock -$132.64 -$509.06 -$155.98
Net borrowings
Total cash flows from financing -$287.81 -$236.81 -$610.56 -$252.51
Effect of exchange rate $6.64 $5.12 -$16.74 $2.72
Change in cash and equivalents -$240.21 $189.59 -$604.66 $153.05
Fundamentals
Market cap $7.99B
Enterprise value N/A
Shares outstanding 95.39M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 2.86
Quick ratio 2.78